Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria: cost-effectiveness analysis.
Matti MarklundLeopold Ndemnge AmindeMary Njeri WanjauBoni M AleAdedayo E OjoClementina E OkoroAbimbola AdegboyeLiping HuangJacob Lennert VeermanJason Hy WuMark D HuffmanDike B OjjiPublished in: BMJ global health (2024)
Our findings support mandating a limit of iTFAs as a cost-saving strategy to reduce the IHD burden in Nigeria.